Skip to content

Kenya

ocds-bidanga-KE-OP00468839

Closedtender

Consulting Services for Stakeholder Engagement — Health Emergency Preparedness Project, Kenya

Original title: Consulting Services for Stakeholder Engagement, Ecosystem Building & Communication in Vaccine and Pharmaceutical Manufacturing for the Kenya BioVax Institute

Deadline

September 30, 2026

Closed
Published on September 15, 2026 at 12:00 AMModified on September 17, 2026 at 01:01 AM

Key information

Type
Consulting & Studies
Location
Kenya
Deadline
September 30, 2026 at 12:00 AMClosed
Estimated Value
Not disclosed
Language of Notice
English

What is this tender about?

Consulting Services for Stakeholder Engagement — Health Emergency Preparedness Project, Kenya is a consulting & studies procurement opportunity published by The Kenya Biovax Institute Limited in Kenya on September 15, 2026. Submissions closed on September 30, 2026. 1 official document is attached below.

| REQUEST FOR EXPRESSIONS OF INTEREST (CONSULTING SERVICES – FIRMS SELECTION) | Country: | Republic of Kenya | Name of Project: | HEALTH EMERGENCY PREPAREDNESS RESPONSE AND RESILIENCE PROJECT | Credit No: | 7405-KE | Project ID: | P180127 | Reference No. | KE-KBI-571330-CS-CQS | ASSIGNMENT TITLE: | CONSULTING SERVICES FOR STAKEHOLDER ENGAGEMENT, ECOSYSTEM BUILDING & STRATEGIC COMMUNICATIONS FOR THE KENYA BIOVAX INSTITUTE 1. The Government of Kenya (GoK) has received financing from the World Bank toward the cost of the Health Emergency Preparedness Response and Resilience (HEPRR) Project and intends to apply part of the proceeds for consulting services.

  • The consulting services (“the Services”) includes Consulting Services for Stakeholder Engagement, Ecosystem Building & Strategic Communications for The Kenya Biovax Institute. The duration of the assignment will be Eight Months from the contract commencement date.
  • The detailed Terms of Reference (ToR) for the assignment can be found at the following Kenya Biovax Institute Limited’s website: www.biovax.go.ke. 4. The Kenya Biovax Institute Limited now invites eligible consulting firms (“Consultants”) to indicate their interest in providing the Services.

Interested Consultants should provide information demonstrating that they have the required qualifications and relevant experience to perform the Services. The shortlisting criteria are: 4.1 Core business and years in business The consulting firm shall be legally registered/incorporated as a consulting entity and shall have its core business providing expertise in stakeholder engagement, institutional development, public sector consulting, health systems strengthening, pharmaceutical or vaccine sector advisory, market shaping and entry strategies or related fields for a minimum period of ten (10) years 4.2 Relevant experience: The consulting firm shall demonstrate having successfully executed, completed and supported at least one (1) assignment of similar nature, scope, scale, and complexity within the last eight (8) years.

Details of similar assignments-Name and address of the client, scope, value, and period should be provided in the submitted proposal including enumeration of these similar past assignments. 4.3 Technical and managerial capability of the firm: The consulting firm shall demonstrate adequate technical depth, financial and business advisory capacity, and managerial capability to undertake this assignment, supported by submitted company profiles, organisational structures, and availability of suitably qualified experts.

Key Experts will not be evaluated at the shortlisting stage. 5. The attention of interested Consultants is drawn to Section III, paragraphs, 3.14, 3.16, and 3.17 of the World Bank’s “Procurement Regulations for IPF Borrowers” First Published July 2016 and Revised Fourth Edition November 2020 (“Procurement Regulations”), setting forth the World Bank’s policy on conflict of interest.

  • Consultants may associate with other firms to enhance their qualifications but should indicate clearly whether the association is in the form of a joint venture and/or a sub-consultancy. In the case of a joint venture, all the partners in the joint venture shall be jointly and severally liable for the entire contract, if selected.
  • A Consultant will be selected in accordance with the Consultant Qualifications Selection (CQS) method set out in the World Bank Procurement Regulations. 8. Further information can be obtained at the address below during office hours 0900 to 1700 hours East African Time (EAT) from Monday to Friday excluding lunch hour (1300 to 1400hours (EAT) and public holidays).
  • Expressions of Interest must be delivered in a written form to the address below (In person, or by email) and be clearly marked “Expression of Interest Consulting Services for Stakeholder Engagement, Ecosystem Building & Strategic Communications for The Kenya Biovax Institute by 30th September 2026 at 1100 hours East African Time. EOI submissions delivered by email should strictly be sent to: HEPRRProcurement@biovax.go.ke Address: Director General/CEO Kenya BioVax Institute Limited Kenya Women Finance Trust- Upper Hill Kiambere- Masaba Road 3rd Floor, Wing A Nairobi, Kenya Tel: +254 775 751 639 E-mail: heprr@biovax.go.ke Copy: procurement@biovax.go.ke

What are the key dates?

  1. Publication

    September 15, 2026

  2. Bid Submission Deadline

    September 30, 2026

  3. Evaluation & Award

    Pending

  4. Contract Signature

    Pending

Procuring Entity

Country
Kenya
Contact person
Serah Muteru

Which documents are available?

Sign in to download the tender documents and be notified automatically of any change to this tender.